| Li, Qifu |
NCT05924620: Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism |
|
|
| Completed | 4 | 60 | RoW | finerenone, Kerendia | Chongqing Medical University | Primary Aldosteronism | 03/24 | 03/24 | | |
NCT06457074: Finerenone for Patients With Primary Aldosteronism (FAIRY) |
|
|
| Recruiting | 4 | 306 | RoW | Finerenone Oral Tablet, Finerenone, Spironolactone Oral Tablet, Spironolactone | Qifu Li, The Affiliated Hospital Of Southwest Medical University, The First Affiliated Hospital of Zhengzhou University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Changzhi Medical College | Primary Aldosteronism | 06/25 | 06/26 | | |
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects |
|
|
| Not yet recruiting | 3 | 408 | RoW | TQF3510 (Semaglutide Injection), Wegovy® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Obesity | 07/26 | 08/26 | | |
| Recruiting | 3 | 344 | RoW | Insulin degludec injection, Tresiba® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Type 2 Diabetes | 12/25 | 12/25 | | |
NCT04403347: Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary Intervention |
|
|
| Recruiting | 1 | 90 | RoW | Innovative Dietary Formulation (Patent ID: CN110250417A), Losartan 50mg per day, Antihypertensive Medication | Chinese Academy of Medical Sciences, Fuwai Hospital, National Natural Science Foundation of China | Hypertension | 01/23 | 09/23 | | |
NCT02035891: Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria |
|
|
| Active, not recruiting | N/A | 160 | RoW | colchicine 0.5mg/d, placebo 0.5mg/d | Chongqing Medical University | Diabetic Nephropathy | 09/19 | 06/23 | | |
HASA, NCT04991961: Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Screening for Primary Aldosteronism |
|
|
| Recruiting | N/A | 330 | RoW | withdraw antihypertensive drugs | Chongqing Medical University | Hypertension, Primary Aldosteronism | 12/22 | 12/23 | | |
ADOPA, NCT04461535: Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism |
|
|
| Completed | N/A | 228 | RoW | Adrenocorticotropic hormone, ACTH | Chongqing Medical University | Primary Aldosteronism | 02/23 | 02/23 | | |
GAPA, NCT06238232: Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism |
|
|
| Recruiting | N/A | 320 | RoW | 68Ga-Pentixafor PET/CT | Qifu Li, The Affiliated Hospital Of Southwest Medical University, West China Hospital, Tongji Hospital, The First Affiliated Hospital of Zhengzhou University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Third Xiangya Hospital of Central South University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Changzhi Medical College, Xiangya Hospital of Central South University | Primary Aldosteronism | 12/26 | 12/27 | | |
| Completed | N/A | 396 | RoW | Captopril Challenge Test | Chongqing Medical University, Chinese PLA General Hospital, Chinese Academy of Medical Sciences, Fuwai Hospital, Tianjin Medical University General Hospital | Primary Aldosteronism | 07/24 | 07/24 | | |
ABOARD, NCT06635993: Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion |
|
|
| Recruiting | N/A | 97 | RoW | 68Ga-Pentixafor PET/CT | Qifu Li, The First Affiliated Hospital of Zhengzhou University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Third Xiangya Hospital of Central South University, The Affiliated Hospital Of Southwest Medical University | Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion | 08/26 | 08/27 | | |
| Recruiting | N/A | 1500 | RoW | no intervention | Chongqing Medical University | Primary Aldosteronism | 12/27 | 12/28 | | |
| Recruiting | N/A | 5000 | RoW | | Chongqing Medical University | Diabetes Mellitus | 07/30 | 07/30 | | |
NCT05743933: Cohort Study of Adrenogenic Autonomic Cortisol Secretion |
|
|
| Not yet recruiting | N/A | 200 | NA | | Chongqing Medical University | Diagnosis, Treatment, Adrenogenic Autonomic Cortisol Secretion | 02/33 | 02/33 | | |
| Li, Fan |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer |
|
|
| Recruiting | 3 | 6000 | Europe, Canada, Japan, US, RoW | Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane | Eli Lilly and Company | Breast Neoplasms | 10/27 | 03/32 | | |
NCT03422835: Robotic Assisted Transanal Total Mesorectal Excision Surgery for Rectal Cancer in Low Site |
|
|
| Not yet recruiting | 2 | 50 | NA | R-TME, R-TaTME | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Rectal Neoplasms | 12/20 | 12/23 | | |
TRIUNITE-02, NCT06709885: HDAC Inhibitor Combination with Chemoimmunotherapy in the Neoadjuvant Treatment of PMMR Locally Advanced Colon Cancer |
|
|
| Recruiting | 2 | 100 | RoW | Chidamide + Tislelizumab + chemotherapy (CapeOX ), CapeOX | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Southwest Hospital, China, Xinqiao Hospital of Chongqing, First Affiliated Hospital of Chongqing Medical University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing University Cancer Hospital, Chongqing General Hospital, Chongqing Traditional Chinese Medicine Hospital, Chongqing Shapingba District People's Hospital, Chongqing Seventh People's Hospital, Chongqing Fifth Hospital RENJI Hospital Chongqing, The 13th People's Hospital of Chongqing | Colon Adenocarcinoma | 09/25 | 09/27 | | |
TRIUNITE-03, NCT06718543: Neoadjuvant Short-Course Radiotherapy with or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer |
|
|
| Not yet recruiting | 2 | 100 | RoW | AK112 with SCRT and CapeOX, short-course radiotherapy, CapeOX, AK112 with SCRT | fan li | Rectal Cancer | 10/26 | 10/27 | | |
NCT05352542: GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma |
|
|
| Terminated | 1 | 10 | RoW | GPC3 Targeting CART Cells | jianming xu, Nanjing Legend Biotech Co. | Advanced Hepatocellular Carcinoma | 07/24 | 07/24 | | |
| Recruiting | N/A | 3500 | RoW | | Tang-Du Hospital, Esaote (Shenzhen) Medical Equipment Co. Ltd, The First Affiliated Hospital, Zhejiang University School of Medicine, Shannxi Provincial People's Hospital, Shengjing Hospital, First Hospital of China Medical University, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Renmin Hospital of Wuhan University, Beijing University of Chinese Medicine Third Affiliated Hospital, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, The First Hospital of Jilin University, The Afffiliated Hospital of Guizhou Medical University, Yan An Hospital Affiliated to Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Third Xiangya Hospital of Central South University, Ruijin Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Anhui Medical University, The Second Hospital of Anhui Medical University, The First Affiliated Hospital of USTC, The Affiliated Hospital of Qingdao University, First Affiliated Hospital of Xinjiang Medical University, Hospital of Northwestern Polytechnical University, GEM Flower Xian Changqing Staff Hospital, Xi'an Central Hospital, The Second Affiliated Hospital of Xi'an Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Guangxi Medical University, Karamay Central Hospital of Xinjiang, The Fourth Affiliated Hospital of Xinjiang Medical University, Xi'an No.1 Hospital, Xianyang Hospital of Yan'an University, General Hospital of Xinjiang Production and Construction Corps, Air Force Medical Center | Healthy, Adults, Carotid Intima-media Thickness, Vascular Stiffness, Chinese | 05/22 | 05/22 | | |
| Completed | N/A | 612 | RoW | VI, DI | fan li | Rectal Cancer | 10/24 | 10/24 | | |
| Recruiting | N/A | 100 | RoW | Small intestine length measurement method | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Small Intestine Length Measurement | 10/23 | 10/23 | | |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
NCT06573424: Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC |
|
|
| Recruiting | N/A | 115 | RoW | Tislelizumab+anlotinib, anlotinib | fan li | Colon Cancer, Immunotherapy | 07/24 | 10/24 | | |
PROBE, NCT06633133: Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision |
|
|
| Recruiting | N/A | 620 | RoW | Virtual ileostomy | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Rectal Cancer | 12/26 | 10/30 | | |
NCT06591572: Single-port Robotic Versus Laparoscopic Transanal Total Mesorectal Excision |
|
|
| Recruiting | N/A | 40 | RoW | Single-port robotic transanal total mesorectal excision, Laparoscopic transanal total mesorectal excision | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Rectal Cancer Patients | 08/25 | 12/25 | | |
NCT05985252: Virtual Ileostomy Versus Conventional Loop Ileostomy |
|
|
| Not yet recruiting | N/A | 500 | RoW | Virtual ileostomy, Diverting ileostomy | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Rectal Neoplasms | 10/25 | 12/25 | | |
NCT05482529: Integrative Omics Analysis for Colorectal Cancer and Metastasis |
|
|
| Recruiting | N/A | 20 | RoW | Integrative omics | fan li | Colorectal Cancer | 12/24 | 12/25 | | |
| Zhu, Yuxi |
| Recruiting | 3 | 315 | RoW | TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Stage III Non-small-cell Lung Cancer | 12/22 | 03/25 | | |
| Gou, Xin |
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| Active, not recruiting | 3 | 496 | Europe, US, RoW | Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone | Jiangsu HengRui Medicine Co., Ltd. | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 12/26 | 12/26 | | |
NCT04738630: Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer |
|
|
| Recruiting | 2 | 110 | RoW | HX008 | Taizhou Hanzhong biomedical co. LTD | Bladder Cancer | 12/22 | 12/23 | | |
NCT06766266: Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment |
|
|
| Not yet recruiting | 1 | 18 | NA | Irinotecan liposome II combination therapy regimen | First Affiliated Hospital of Chongqing Medical University | Non-Muscle Invasive Bladder Urothelial Carcinoma | 04/25 | 12/25 | | |
| He, Weiyang |
CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) |
|
|
| Active, not recruiting | 3 | 900 | Europe, Canada, Japan, US, RoW | Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib | Eli Lilly and Company | Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6 | 02/24 | 10/27 | | |
NCT04492293: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer |
|
|
| Recruiting | 2 | 115 | RoW | ICP-192 | Beijing InnoCare Pharma Tech Co., Ltd. | Bladder Urothelial Cancer | 12/24 | 06/25 | | |
| Cheng, Oumei |
| Active, not recruiting | 4 | 800 | RoW | Sodium Oligomannate Capsules (GV-971) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 06/25 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
